1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Global Market by Molecule Type 43
3.1 Market Overview by Molecule Type 43
3.2 Small Molecule 45
3.3 Large Molecule 46
4 Segmentation of Global Market by Drug Class 47
4.1 Market Overview by Drug Class 47
4.2 Monoclonal Antibodies (mAbs) 49
4.3 Immunoglobulin 50
4.4 Insulin 51
4.5 Vaccines 52
4.6 Cytokines 53
4.7 Peptide Hormone 54
4.8 Blood Factors 55
4.9 Other Drug Classes 56
5 Segmentation of Global Market by Delivery 57
5.1 Market Overview by Delivery 57
5.2 Pre-filled Syringe 59
5.3 Infusions 60
5.4 Other Deliveries 61
6 Segmentation of Global Market by Application 62
6.1 Market Overview by Application 62
6.2 Oncology 64
6.3 Infectious Diseases 65
6.4 Autoimmune Diseases 66
6.5 Cardiovascular Diseases 67
6.6 Pain 68
6.7 Neurology 69
6.8 Other Applications 70
7 Segmentation of Global Market by Distribution Channel 71
7.1 Market Overview by Distribution Channel 71
7.2 Hospital Pharmacy 73
7.3 Retail Pharmacy 74
7.4 E-Commerce 75
8 Segmentation of Global Market by Region 76
8.1 Geographic Market Overview 2019-2030 76
8.2 North America Market 2019-2030 by Country 80
8.2.1 Overview of North America Market 80
8.2.2 U.S. 84
8.2.3 Canada 87
8.2.4 Mexico 89
8.3 European Market 2019-2030 by Country 91
8.3.1 Overview of European Market 91
8.3.2 Germany 95
8.3.3 U.K. 97
8.3.4 France 99
8.3.5 Spain 101
8.3.6 Italy 103
8.3.7 Russia 105
8.3.8 Rest of European Market 108
8.4 Asia-Pacific Market 2019-2030 by Country 110
8.4.1 Overview of Asia-Pacific Market 110
8.4.2 Japan 114
8.4.3 China 117
8.4.4 Australia 119
8.4.5 India 121
8.4.6 South Korea 123
8.4.7 Rest of APAC Region 125
8.5 South America Market 2019-2030 by Country 127
8.5.1 Argentina 130
8.5.2 Brazil 132
8.5.3 Chile 134
8.5.4 Rest of South America Market 136
8.6 MEA Market 2019-2030 by Country 137
8.6.1 UAE 140
8.6.2 Saudi Arabia 142
8.6.3 South Africa 144
8.6.4 Other National Markets 146
9 Competitive Landscape 147
9.1 Overview of Key Vendors 147
9.2 New Product Launch, Partnership, Investment, and M&A 150
9.3 Company Profiles 151
Amgen Inc. 151
Baxter International Inc. 153
Eli Lilly and Company 154
Gilead Sciences Inc. 155
GlaxoSmithKline PLC 156
Johnson & Johnson 157
Merck & Co. Inc. 158
Moderna, Inc. 159
Novartis AG 160
Novo Nordisk AS 161
Pfizer Inc. 162
Sanofi SA 163
Teva Pharmaceuticals Industries Ltd. 164
RELATED REPORTS 165